165 related articles for article (PubMed ID: 9689425)
1. Effects of boswellic acids extracted from a herbal medicine on the biosynthesis of leukotrienes and the course of experimental autoimmune encephalomyelitis.
Wildfeuer A; Neu IS; Safayhi H; Metzger G; Wehrmann M; Vogel U; Ammon HP
Arzneimittelforschung; 1998 Jun; 48(6):668-74. PubMed ID: 9689425
[TBL] [Abstract][Full Text] [Related]
2. Suppression of experimental autoimmune encephalomyelitis by a new specific inhibitor of leukotriene biosynthesis.
Neu IS; Wildfeuer A; Mallinger J; Mehlber L
Arzneimittelforschung; 1992 Sep; 42(9):1083-6. PubMed ID: 1332726
[TBL] [Abstract][Full Text] [Related]
3. L-663,536 (MK-886) (3-[1-(4-chlorobenzyl)-3-t-butyl-thio-5-isopropylindol-2-yl]-2,2 - dimethylpropanoic acid), a novel, orally active leukotriene biosynthesis inhibitor.
Gillard J; Ford-Hutchinson AW; Chan C; Charleson S; Denis D; Foster A; Fortin R; Leger S; McFarlane CS; Morton H
Can J Physiol Pharmacol; 1989 May; 67(5):456-64. PubMed ID: 2548691
[TBL] [Abstract][Full Text] [Related]
4. Workup-dependent formation of 5-lipoxygenase inhibitory boswellic acid analogues.
Schweizer S; von Brocke AF; Boden SE; Bayer E; Ammon HP; Safayhi H
J Nat Prod; 2000 Aug; 63(8):1058-61. PubMed ID: 10978197
[TBL] [Abstract][Full Text] [Related]
5. Platelets, neutrophils, and vasoconstriction after arterial injury by angioplasty in pigs: effects of MK-886, a leukotriene biosynthesis inhibitor.
Provost P; Borgeat P; Merhi Y
Br J Pharmacol; 1998 Jan; 123(2):251-8. PubMed ID: 9489613
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of antiinflammatory actions of curcumine and boswellic acids.
Ammon HP; Safayhi H; Mack T; Sabieraj J
J Ethnopharmacol; 1993 Mar; 38(2-3):113-9. PubMed ID: 8510458
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of leukotriene B4 formation in rat peritoneal neutrophils by an ethanolic extract of the gum resin exudate of Boswellia serrata.
Ammon HP; Mack T; Singh GB; Safayhi H
Planta Med; 1991 Jun; 57(3):203-7. PubMed ID: 1654575
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by boswellic acids of human leukocyte elastase.
Safayhi H; Rall B; Sailer ER; Ammon HP
J Pharmacol Exp Ther; 1997 Apr; 281(1):460-3. PubMed ID: 9103531
[TBL] [Abstract][Full Text] [Related]
9. Defined Structure-Activity Relationships of Boswellic Acids Determine Modulation of Ca2+ Mobilization and Aggregation of Human Platelets by Boswellia serrata Extracts.
Siemoneit U; Tausch L; Poeckel D; Paul M; Northoff H; Koeberle A; Jauch J; Werz O
Planta Med; 2017 Aug; 83(12-13):1020-1027. PubMed ID: 28403501
[TBL] [Abstract][Full Text] [Related]
10. Boswellic acids: novel, specific, nonredox inhibitors of 5-lipoxygenase.
Safayhi H; Mack T; Sabieraj J; Anazodo MI; Subramanian LR; Ammon HP
J Pharmacol Exp Ther; 1992 Jun; 261(3):1143-6. PubMed ID: 1602379
[TBL] [Abstract][Full Text] [Related]
11. [Boswellic acids (components of frankincense) as the active principle in treatment of chronic inflammatory diseases].
Ammon HP
Wien Med Wochenschr; 2002; 152(15-16):373-8. PubMed ID: 12244881
[TBL] [Abstract][Full Text] [Related]
12. Effects of the new 5-lipoxygenase inhibitor E6080 on leukotriene release in vitro.
Sakuma Y; Katayama S; Tsunoda H; Abe S; Yamatsu I; Katayama K
Int Arch Allergy Immunol; 1992; 97(4):267-73. PubMed ID: 1375926
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the immune system by Boswellia serrata extracts and boswellic acids.
Ammon HP
Phytomedicine; 2010 Sep; 17(11):862-7. PubMed ID: 20696559
[TBL] [Abstract][Full Text] [Related]
14. Medicinal plants from nepal: evaluation as inhibitors of leukotriene biosynthesis.
Kumar S; Ziereis K; Wiegrebe W; Müller K
J Ethnopharmacol; 2000 Jun; 70(3):191-5. PubMed ID: 10837982
[TBL] [Abstract][Full Text] [Related]
15. On the interference of boswellic acids with 5-lipoxygenase: mechanistic studies in vitro and pharmacological relevance.
Siemoneit U; Pergola C; Jazzar B; Northoff H; Skarke C; Jauch J; Werz O
Eur J Pharmacol; 2009 Mar; 606(1-3):246-54. PubMed ID: 19374837
[TBL] [Abstract][Full Text] [Related]
16. Phytochemical Analysis and Anti-cancer Investigation of Boswellia serrata Bioactive Constituents In Vitro.
Ahmed HH; Abd-Rabou AA; Hassan AZ; Kotob SE
Asian Pac J Cancer Prev; 2015; 16(16):7179-88. PubMed ID: 26514509
[TBL] [Abstract][Full Text] [Related]
17. Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid.
Safayhi H; Sailer ER; Ammon HP
Mol Pharmacol; 1995 Jun; 47(6):1212-6. PubMed ID: 7603462
[TBL] [Abstract][Full Text] [Related]
18. Enhanced absorption of boswellic acids by a lecithin delivery form (Phytosome(®)) of Boswellia extract.
Hüsch J; Bohnet J; Fricker G; Skarke C; Artaria C; Appendino G; Schubert-Zsilavecz M; Abdel-Tawab M
Fitoterapia; 2013 Jan; 84():89-98. PubMed ID: 23092618
[TBL] [Abstract][Full Text] [Related]
19. Anti-tumor and anti-carcinogenic activities of triterpenoid, beta-boswellic acid.
Huang MT; Badmaev V; Ding Y; Liu Y; Xie JG; Ho CT
Biofactors; 2000; 13(1-4):225-30. PubMed ID: 11237186
[TBL] [Abstract][Full Text] [Related]
20. Cytostatic and apoptosis-inducing activity of boswellic acids toward malignant cell lines in vitro.
Hostanska K; Daum G; Saller R
Anticancer Res; 2002; 22(5):2853-62. PubMed ID: 12530009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
